|
humans |
63 |
|
male |
37 |
|
female |
35 |
|
animals |
34 |
|
middle aged |
30 |
|
chinese |
28 |
|
adult |
25 |
|
hong kong |
21 |
|
karyotyping |
20 |
|
cohort studies |
19 |
|
genetic predisposition to disease |
19 |
|
hong kong - epidemiology |
19 |
|
mice |
19 |
|
aged |
18 |
|
adolescent |
17 |
|
medical sciences |
16 |
|
molecular sequence data |
16 |
|
homozygote |
14 |
|
infant |
14 |
|
oncology |
14 |
|
polymorphism, single nucleotide - genetics |
14 |
|
antigens, cd - genetics |
13 |
|
cell adhesion molecules - genetics |
13 |
|
child |
13 |
|
chromosome aberrations |
13 |
|
l-lactate dehydrogenase - blood |
13 |
|
breast cancer |
12 |
|
child, preschool |
12 |
|
colorectal cancer |
12 |
|
translocation, genetic |
12 |
|
cell adhesion molecules - genetics - metabolism |
11 |
|
cercopithecus aethiops |
11 |
|
cho cells - virology |
11 |
|
coronavirus |
11 |
|
cricetinae |
11 |
|
cricetulus |
11 |
|
disease models, animal |
11 |
|
intestine, small - physiology |
11 |
|
lectins, c-type - genetics - metabolism |
11 |
|
lung - physiology - virology |
11 |
|
proteasome endopeptidase complex - metabolism |
11 |
|
receptors, cell surface - genetics - metabolism |
11 |
|
sars coronavirus |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
tandem repeat sequences |
11 |
|
vero cells - virology |
11 |
|
cell line, tumor |
10 |
|
immunoglobulin heavy chains - genetics |
10 |
|
medical humanities |
10 |
|
mice, nude |
10 |
|
phenotype |
10 |
|
transplantation, heterologous |
10 |
|
antigens, cd44 - genetics - metabolism |
9 |
|
cell division |
9 |
|
china - ethnology |
9 |
|
fact-c |
9 |
|
lymphoma, follicular - genetics - pathology |
9 |
|
lymphoma, large b-cell, diffuse - genetics - pathology |
9 |
|
neoplasm transplantation |
9 |
|
prognosis |
9 |
|
stomach neoplasms - genetics - pathology |
9 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
8 |
|
in situ hybridization, fluorescence |
8 |
|
mice, knockout |
8 |
|
quality of life |
8 |
|
advanced breast cancer |
7 |
|
anchor |
7 |
|
asian continental ancestry group |
7 |
|
bone marrow transplantation |
7 |
|
cell transformation, neoplastic |
7 |
|
china |
7 |
|
chromosome aberrations - genetics |
7 |
|
colorectal neoplasm |
7 |
|
cost-of-illness |
7 |
|
cytogenetics |
7 |
|
direct medical cost |
7 |
|
disease progression |
7 |
|
disease-free survival |
7 |
|
epidermal growth factor receptor |
7 |
|
health care service provider |
7 |
|
immunophenotyping |
7 |
|
immunotherapy |
7 |
|
mutation |
7 |
|
neoplasm proteins - analysis |
7 |
|
non-small-cell lung cancer |
7 |
|
prognostic factors |
7 |
|
remission induction |
7 |
|
repressor proteins |
7 |
|
responsiveness |
7 |
|
service utilization |
7 |
|
sf-12 |
7 |
|
treatment outcome |
7 |
|
tyrosine kinase inhibitors |
7 |
|
acute myeloid leukemia |
6 |
|
acute promyelocytic leukaemia |
6 |
|
acute promyelocytic leukemia |
6 |
|
all-trans retinoic acid |
6 |
|
anti-vegf |
6 |
|
apoptosis - drug effects |
6 |
|
base sequence |
6 |
|
beta-thalassemia - genetics |
6 |
|
bevacizumab |
6 |
|
case-control studies |
6 |
|
chromosomes, human, pair 1 - genetics |
6 |
|
confirmatory factor analysis |
6 |
|
diagnosis, differential |
6 |
|
empathy |
6 |
|
family health |
6 |
|
fatal outcome |
6 |
|
film |
6 |
|
gene expression profiling |
6 |
|
herpesvirus 4, human - genetics - isolation & purification |
6 |
|
heterozygote |
6 |
|
leukaemia |
6 |
|
life tables |
6 |
|
measurement invariance |
6 |
|
mode of administration |
6 |
|
neoplasm metastasis |
6 |
|
oncogene proteins, fusion - genetics |
6 |
|
oncogenes |
6 |
|
papillomaviridae - genetics |
6 |
|
perceived need |
6 |
|
prevalence |
6 |
|
psychological distress |
6 |
|
pterygium |
6 |
|
ranibizumab |
6 |
|
reflective thinking |
6 |
|
reliability |
6 |
|
retrospective studies |
6 |
|
supportive care |
6 |
|
supportive care needs |
6 |
|
survival analysis |
6 |
|
validity |
6 |
|
x chromosome |
6 |
|
acid phosphatase - analysis |
5 |
|
adenoviridae - immunology |
5 |
|
age of onset |
5 |
|
aged, 80 and over |
5 |
|
alleles |
5 |
|
aneuploidy |
5 |
|
antigens, cd - blood |
5 |
|
antineoplastic agents - therapeutic use |
5 |
|
blotting, southern |
5 |
|
cancer progression |
5 |
|
cancer survivors |
5 |
|
carcinoma, squamous cell - ethnology - genetics - pathology |
5 |
|
carcinoma, squamous cell - genetics - pathology |
5 |
|
cell line, transformed |
5 |
|
cells, cultured |
5 |
|
childhood lymphoma |
5 |
|
chromatography, high pressure liquid |
5 |
|
chromosome deletion |
5 |
|
chromosomes, human - ultrastructure |
5 |
|
chromosomes, human, pair 4 |
5 |
|
chromosomes, human, pair 6 - genetics |
5 |
|
chromosomes, human, pair 9 - genetics |
5 |
|
cytokeratin |
5 |
|
dendritic cells - immunology |
5 |
|
epithelial cells - cytology |
5 |
|
epstein-barr virus |
5 |
|
epstein-barr virus infections - immunology - therapy |
5 |
|
epstein-barr virus nuclear antigens - immunology |
5 |
|
esophageal neoplasms - ethnology - genetics - pathology |
5 |
|
esophageal neoplasms - genetics - pathology |
5 |
|
flow cytometry |
5 |
|
genetic vectors |
5 |
|
genotype |
5 |
|
herpesvirus 4, human - immunology |
5 |
|
hpv 16 e6/e7 |
5 |
|
human prostate epithelial cell |
5 |
|
humanities |
5 |
|
illness perceptions |
5 |
|
immortalization |
5 |
|
immunization, passive |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
keratins - analysis |
5 |
|
keratins - metabolism |
5 |
|
methotrexate - administration & dosage |
5 |
|
mice, inbred balb c |
5 |
|
molecular genetics |
5 |
|
nasopharyngeal carcinoma |
5 |
|
nasopharyngeal neoplasms - immunology - pathology - therapy - virology |
5 |
|
nucleic acid hybridization |
5 |
|
oncogene proteins, viral - genetics |
5 |
|
open reading frames |
5 |
|
optimism |
5 |
|
papillomavirus e7 proteins |
5 |
|
pericardial effusion |
5 |
|
polymorphism, genetic |
5 |
|
precursor cell lymphoblastic leukemia-lymphoma - diagnosis - drug therapy - genetics |
5 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics |
5 |
|
prostate - cytology |
5 |
|
proto-oncogenes |
5 |
|
recurrence |
5 |
|
retroviridae |
5 |
|
screening |
5 |
|
sequence deletion |
5 |
|
sex chromosome aberrations - diagnosis - genetics |
5 |
|
symptom distress |
5 |
|
t-lymphocytes, cytotoxic - immunology |
5 |
|
telomerase |
5 |
|
telomerase - genetics |
5 |
|
tomography, x-ray computed |
5 |
|
trisomy |
5 |
|
tumor cells, cultured - chemistry - pathology |
5 |
|
tumor cells, cultured - pathology |
5 |
|
undergraduate |
5 |
|
viral matrix proteins - immunology |
5 |
|
y chromosome |
5 |
|
adaptation, psychological |
4 |
|
adult acute lymphoblastic leukemia |
4 |
|
age factors |
4 |
|
amino acid sequence |
4 |
|
antibody specificity |
4 |
|
anxiety |
4 |
|
asian continental ancestry group - genetics |
4 |
|
b-lymphocytes - drug effects - immunology - metabolism |
4 |
|
beta-thalassemia - blood - epidemiology - genetics |
4 |
|
bioethics |
4 |
|
biopsy |
4 |
|
bone marrow cells - immunology - metabolism |
4 |
|
breast neoplasms - genetics |
4 |
|
breast neoplasms - prevention & control - radiotherapy - surgery - therapy |
4 |
|
cancer |
4 |
|
cancer care |
4 |
|
cancer vaccines |
4 |
|
carcinoma, hepatocellular - immunology - pathology - therapy |
4 |
|
cell cycle - physiology |
4 |
|
cell line |
4 |
|
cell proliferation - drug effects |
4 |
|
cell transformation, neoplastic - genetics |
4 |
|
childhood all |
4 |
|
chloramphenicol succinate |
4 |
|
chromosomes, human, pair 1 |
4 |
|
chromosomes, human, pair 12 |
4 |
|
chromosomes, human, pair 14 |
4 |
|
chromosomes, human, pair 15 |
4 |
|
chromosomes, human, pair 17 |
4 |
|
chromosomes, human, pair 5 |
4 |
|
chromosomes, human, pair 9 |
4 |
|
cost-benefit analysis |
4 |
|
cost-effectiveness analysis |
4 |
|
cyclophosphamide - therapeutic use |
4 |
|
cytarabine - administration & dosage |
4 |
|
cytoplasmic granules - ultrastructure |
4 |
|
daunorubicin - administration & dosage |
4 |
|
decision making |
4 |
|
depression |
4 |
|
diploidy |
4 |
|
dna methylation |
4 |
|
dna, neoplasm - genetics |
4 |
|
dna-binding proteins - genetics |
4 |
|
drug resistance, neoplasm - genetics |
4 |
|
early detection of cancer - economics |
4 |
|
epigenetics |
4 |
|
estrogen receptor alpha - biosynthesis - genetics |
4 |
|
event-free survival |
4 |
|
eyelids |
4 |
|
factor xii deficiency - complications - ethnology |
4 |
|
fetal hemoglobin - genetics - metabolism |
4 |
|
fish |
4 |
|
follow-up studies |
4 |
|
genetic variation |
4 |
|
globins - genetics |
4 |
|
head and neck |
4 |
|
health care rationing - economics |
4 |
|
hematoma, subdural - etiology |
4 |
|
homeodomain proteins - genetics - physiology |
4 |
|
hox |
4 |
|
immunologic memory - immunology |
4 |
|
immunosuppressive agents - therapeutic use |
4 |
|
incidence |
4 |
|
interleukin-10 - deficiency - genetics - immunology - metabolism |
4 |
|
interleukin-7 - pharmacology |
4 |
|
leukemia, megakaryoblastic, acute - genetics |
4 |
|
leukemia, myeloid - genetics - pathology |
4 |
|
leukemia, myeloid, acute - genetics |
4 |
|
leukemia, promyelocytic, acute - drug therapy - mortality |
4 |
|
longitudinal |
4 |
|
lymphopoiesis - immunology |
4 |
|
mammography - economics |
4 |
|
markov chains |
4 |
|
medical education |
4 |
|
metastatic disease |
4 |
|
mice, inbred c57bl |
4 |
|
mll-een |
4 |
|
myeloproliferation |
4 |
|
neoplasms, multiple primary - diagnosis - pathology - therapy |
4 |
|
neural crest |
4 |
|
neuroectodermal tumors, primitive, peripheral - diagnosis - pathology - therapy |
4 |
|
neurofibromatosis |
4 |
|
neurofibromatosis 1 - diagnosis - pathology - therapy |
4 |
|
nuclear receptor co-repressor 2 - genetics |
4 |
|
oncogene proteins, fusion - analysis |
4 |
|
operative |
4 |
|
palliative care |
4 |
|
patient satisfaction |
4 |
|
perceived needs |
4 |
|
policy making |
4 |
|
precursor cell lymphoblastic leukemia-lymphoma - drug therapy - therapy |
4 |
|
prenatal diagnosis |
4 |
|
primitive neuroectodermal tumor |
4 |
|
prospective studies |
4 |
|
proto-oncogene proteins |
4 |
|
quality-adjusted life years |
4 |
|
resource allocation |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
salvage therapy |
4 |
|
src homology domains |
4 |
|
student reflection |
4 |
|
students, medical - psychology |
4 |
|
suffering |
4 |
|
surgical procedures |
4 |
|
survival rate |
4 |
|
t-lymphocytes - immunology - metabolism |
4 |
|
trajectory patterns |
4 |
|
transplantation conditioning |
4 |
|
tretinoin - therapeutic use |
4 |
|
tumor markers, biological - genetics |
4 |
|
tumor markers, biological - genetics - metabolism |
4 |
|
unmet information needs |
4 |
|
validation |
4 |
|
wellbeing |
4 |
|
whole-body irradiation |
4 |
|
12) (q11 |
3 |
|
21) |
3 |
|
6-mercaptopurine - administration & dosage |
3 |
|
acute disease |
3 |
|
acute leukaemia |
3 |
|
acute lymphoblastic leukaemia |
3 |
|
adoptive immunotherapy |
3 |
|
adrenal cortex hormones - therapeutic use |
3 |
|
age-friendly |
3 |
|
ageing infusion education |
3 |
|
all |
3 |
|
alpha-thalassemia - genetics |
3 |
|
alternative splicing |
3 |
|
american college students |
3 |
|
aml1 amplification |
3 |
|
anemia, macrocytic - etiology |
3 |
|
anemia, megaloblastic - epidemiology - etiology - pathology |
3 |
|
anemia, pernicious - complications |
3 |
|
antibodies, monoclonal |
3 |
|
antibodies, monoclonal, murine-derived |
3 |
|
antigens, cd - analysis |
3 |
|
antigens, cd3 |
3 |
|
antigens, cd8 - metabolism |
3 |
|
antigens, differentiation, t-lymphocyte - metabolism |
3 |
|
antilymphocyte serum - therapeutic use |
3 |
|
antineoplastic agents - administration & dosage - adverse effects |
3 |
|
antineoplastic combined chemotherapy protocols - administration & dosage - adverse effects |
3 |
|
apoptosis - physiology |
3 |
|
artificial gene fusion |
3 |
|
asparaginase - administration & dosage |
3 |
|
aspiration cytology, fine-needle |
3 |
|
ayahuasca |
3 |
|
b-lymphocytes - immunology |
3 |
|
biological marker |
3 |
|
biopsy, fine-needle |
3 |
|
blood cells - chemistry |
3 |
|
blood transfusion |
3 |
|
blotting, western |
3 |
|
bone marrow - drug effects - metabolism |
3 |
|
bone marrow - drug effects - physiology |
3 |
|
brain - metabolism |
3 |
|
breast neoplasms - metabolism |
3 |
|
burkitt lymphoma - epidemiology - immunology |
3 |
|
carrier proteins - chemistry - genetics - metabolism |
3 |
|
caspase 3 |
3 |
|
caspases - drug effects - metabolism |
3 |
|
cataract |
3 |
|
cd56 |
3 |
|
cell cycle |
3 |
|
cell division - physiology |
3 |
|
cell nucleus |
3 |
|
cell nucleus - metabolism |
3 |
|
cell transformation, viral - genetics |
3 |
|
chemotherapy |
3 |
|
childhood leukaemia |
3 |
|
chimera |
3 |
|
chinese people |
3 |
|
chinese undergraduates |
3 |
|
chloramphenicol |
3 |
|
chloramphenicol - analogs & derivatives - analysis - pharmacology - toxicity |
3 |
|
chloramphenicol - analogs and derivatives - metabolism |
3 |
|
chromosome banding |
3 |
|
chromosome inversion |
3 |
|
chromosomes, human, pair 11 |
3 |
|
chromosomes, human, pair 12 - genetics |
3 |
|
chromosomes, human, pair 19 |
3 |
|
chromosomes, human, pair 20 |
3 |
|
chromosomes, human, pair 21 |
3 |
|
chromosomes, human, pair 3 |
3 |
|
chromosomes, human, pair 8 |
3 |
|
chronic lymphocytic leukemia |
3 |
|
chronic lymphoproliferative disorders |
3 |
|
clone cells |
3 |
|
cloning, molecular |
3 |
|
cluster analysis |
3 |
|
clustering |
3 |
|
combined modality therapy |
3 |
|
common infections |
3 |
|
comorbidity |
3 |
|
consumer satisfaction |
3 |
|
core binding factor alpha 2 subunit |
3 |
|
cranial irradiation |
3 |
|
cross-cultural differences |
3 |
|
cross-sectional studies |
3 |
|
curriculum - standards |
3 |
|
cyclophosphamide - administration & dosage |
3 |
|
cyclosporine |
3 |
|
cyclosporine - therapeutic use |
3 |
|
cytarabine - administration and dosage - adverse effects |
3 |
|
cytogenetic analysis |
3 |
|
cytoplasm - metabolism |
3 |
|
day care - statistics & numerical data |
3 |
|
dendritic cells, follicular - pathology |
3 |
|
deoxyribonucleases, type ii site-specific |
3 |
|
dexamethasone - administration & dosage - adverse effects |
3 |
|
dna mutational analysis |
3 |
|
dna, intergenic - genetics |
3 |
|
dna, neoplasm - analysis |
3 |
|
dna, viral - analysis |
3 |
|
dna-binding proteins - genetics - metabolism |
3 |
|
down syndrome - genetics |
3 |
|
drug resistance |
3 |
|
dynamin i |
3 |
|
dynamin iii |
3 |
|
dynamins |
3 |
|
education, medical, undergraduate - methods |
3 |
|
embryo, nonmammalian |
3 |
|
embryonic and fetal development |
3 |
|
endocytosis |
3 |
|
endocytosis - physiology |
3 |
|
endophilin |
3 |
|
endophilin family |
3 |
|
enzyme inhibitors - metabolism |
3 |
|
epidemiology |
3 |
|
epithelial cells |
3 |
|
epstein-barr virus infections - blood - genetics - virology |
3 |
|
erythrocytes - chemistry |
3 |
|
essential thrombocythaemia |
3 |
|
essential thrombocythemia |
3 |
|
ets-domain protein elk-1 - metabolism |
3 |
|
extra eleven nineteen (een) |
3 |
|
fetal diseases - diagnosis - enzymology - genetics |
3 |
|
fetal hemoglobin - analysis |
3 |
|
fetal hemoglobin - genetics |
3 |
|
flow cytometry - methods |
3 |
|
forkhead transcription factors - metabolism |
3 |
|
foxm1 |
3 |
|
foxo3a |
3 |
|
fusion proteins, bcr-abl - genetics |
3 |
|
gene expression regulation |
3 |
|
gene expression regulation, developmental |
3 |
|
gene expression regulation, developmental - drug effects |
3 |
|
gene expression regulation, leukemic |
3 |
|
gene expression regulation, neoplastic |
3 |
|
gene knockdown techniques |
3 |
|
gene rearrangement |
3 |
|
gene rearrangement, beta-chain t-cell antigen receptor |
3 |
|
genes, homeobox - physiology |
3 |
|
genes, myb |
3 |
|
glycoproteins - administration & dosage |
3 |
|
glycosylphosphatidyl-inositol-linked proteins |
3 |
|
glycosylphosphatidylinositols - blood |
3 |
|
granular lymphocytes |
3 |
|
gtp phosphohydrolases - metabolism |
3 |
|
haploidy |
3 |
|
hematologic neoplasms - pathology |
3 |
|
hematopoiesis - drug effects - genetics - physiology |
3 |
|
hematopoietic stem cells - pathology - physiology |
3 |
|
hemoglobins - analysis |
3 |
|
hemoglobins - biosynthesis - drug effects |
3 |
|
hemoglobinuria, paroxysmal - blood |
3 |
|
hemorrhage - etiology |
3 |
|
hepatoblastoma - genetics - pathology |
3 |
|
hepatomegaly - etiology |
3 |
|
hospital records |
3 |
|
human bone marrow |
3 |
|
human bone marrow and liver |
3 |
|
huntington disease - genetics |
3 |
|
hyperdiploid |
3 |
|
ileal diseases - etiology |
3 |
|
ileal neoplasms - complications - diagnosis - pathology - radiotherapy - surgery |
3 |
|
immunophenotype |
3 |
|
in situ hybridization, fluorescence - methods |
3 |
|
individualism-collectivism |
3 |
|
infant, newborn |
3 |
|
infection - epidemiology |
3 |
|
inheritance patterns |
3 |
|
intercellular signaling peptides and proteins - administration & dosage |
3 |
|
intergenerational exchange |
3 |
|
interphase - genetics |
3 |
|
intestinal obstruction - etiology |
3 |
|
intracellular signaling peptides and proteins - genetics |
3 |
|
karyotypic changes |
3 |
|
kidney - drug effects - physiology |
3 |
|
large granular lymphocytic leukemia |
3 |
|
learning objectives |
3 |
|
lens |
3 |
|
leucovorin - administration & dosage |
3 |
|
leukemia |
3 |
|
leukemia - epidemiology |
3 |
|
leukemia - metabolism |
3 |
|
leukemia, lymphocytic, chronic, b-cell - genetics |
3 |
|
leukemia, lymphoid - ethnology - pathology - therapy |
3 |
|
leukemia, monocytic, acute - genetics |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics - pathology |
3 |
|
leukemia, myeloid - genetics - physiopathology - therapy |
3 |
|
leukemia, myeloid, acute - chemically induced |
3 |
|
leukemia, myeloid, acute - drug therapy - mortality |
3 |
|
leukemia, myeloid, acute - genetics - pathology |
3 |
|
leukemia, myelomonocytic, chronic - genetics |
3 |
|
leukemia, promyelocytic, acute - drug therapy |
3 |
|
leukemia-lymphoma, adult t-cell - epidemiology - immunology |
3 |
|
leukocyte count |
3 |
|
leukocytes - chemistry |
3 |
|
life education |
3 |
|
linkage disequilibrium |
3 |
|
liver - drug effects - physiology |
3 |
|
liver neoplasms - genetics - pathology |
3 |
|
lymph nodes - pathology |
3 |
|
lymphocytosis - genetics - immunology - microbiology |
3 |
|
lymphoma, b-cell - complications - drug therapy |
3 |
|
lymphoma, follicular - complications - diagnosis - pathology - radiotherapy - surgery |
3 |
|
lymphoma, t-cell - complications - drug therapy |
3 |
|
lymphoproliferative diseases |
3 |
|
lymphoproliferative disorders - epidemiology - pathology |
3 |
|
medical curriculum |
3 |
|
megakaryoblastic transformation |
3 |
|
megakaryocytes - pathology |
3 |
|
megaloblastic anaemia |
3 |
|
metabolism |
3 |
|
methylprednisolone - therapeutic use |
3 |
|
mice, transgenic |
3 |
|
micrornas |
3 |
|
micrornas - blood - genetics |
3 |
|
mitochondria - drug effects - physiology |
3 |
|
mitosis |
3 |
|
mitosis - physiology |
3 |
|
mitoxantrone |
3 |
|
mitoxantrone - administration & dosage - adverse effects |
3 |
|
mitoxantrone - administration and dosage - adverse effects |
3 |
|
molecular cytogenetics |
3 |
|
morpholines - administration & dosage |
3 |
|
multigene family |
3 |
|
multivariate analysis |
3 |
|
myelodysplasia |
3 |
|
myelodysplastic syndromes - chemically induced |
3 |
|
myelodysplastic syndromes - genetics |
3 |
|
myelofibrosis |
3 |
|
myeloid cells - pathology - physiology |
3 |
|
myeloid-lymphoid leukemia protein |
3 |
|
myeloid-lymphoid leukemia protein - genetics |
3 |
|
myeloid-lymphoid leukemia protein - metabolism |
3 |
|
nasopharyngeal neoplasms |
3 |
|
nasopharyngeal neoplasms - blood - genetics - virology |
3 |
|
near-haploid |
3 |
|
neoplasm proteins - genetics |
3 |
|
neoplasm recurrence, local |
3 |
|
neoplasm staging |
3 |
|
neoplasms, second primary - chemically induced |
3 |
|
nerve tissue proteins - metabolism |
3 |
|
neurons - metabolism |
3 |
|
novel therapy |
3 |
|
nuclear proteins - genetics |
3 |
|
nuclear proteins - metabolism |
3 |
|
nucleocytoplasmic shuttling |
3 |
|
nucleocytoplasmic transport proteins |
3 |
|
oligonucleotide array sequence analysis |
3 |
|
oncogene proteins - genetics |
3 |
|
oncogene proteins, fusion - metabolism |
3 |
|
outcome |
3 |
|
outcome assessment (health care) |
3 |
|
ovary - cytology |
3 |
|
oxidation-reduction |
3 |
|
oxidative stress |
3 |
|
pain - etiology |
3 |
|
pancytopenia - etiology |
3 |
|
paroxysmal nocturnal hemoglobinuria |
3 |
|
pastoral care |
3 |
|
pbl |
3 |
|
personal satisfaction |
3 |
|
phacoemulsification |
3 |
|
philadelphia chromosome |
3 |
|
phosphoric monoester hydrolases - metabolism |
3 |
|
pilot projects |
3 |
|
platelet count |
3 |
|
point mutation |
3 |
|
population mixing |
3 |
|
precursor b-cell lymphoblastic leukemia-lymphoma - genetics |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - blood - drug therapy - epidemiology - pathology - radiotherapy |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - drug therapy - mortality |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - epidemiology |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - epidemiology - immunology |
3 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics - immunology |
3 |
|
prednisone - administration & dosage |
3 |
|
pregnancy |
3 |
|
primary follicular lymphoma |
3 |
|
primary myelofibrosis - genetics |
3 |
|
problem-based learning |
3 |
|
promoter regions, genetic |
3 |
|
protein binding |
3 |
|
protein synthesis inhibitors - analysis |
3 |
|
protein transport |
3 |
|
proteins - genetics - metabolism |
3 |
|
proteins - immunology - metabolism - physiology |
3 |
|
proto-oncogene proteins c-ets |
3 |
|
pure red cell aplasia |
3 |
|
pyruvate kinase - deficiency - genetics |
3 |
|
pyruvate kinase deficiency |
3 |
|
q13) |
3 |
|
quantitative trait loci - genetics |
3 |
|
questionaire |
3 |
|
radiology and nuclear medicine |
3 |
|
radiotherapy, adjuvant |
3 |
|
ras proteins - metabolism |
3 |
|
rat liver and kidney mitochondria |
3 |
|
rats |
3 |
|
real-time polymerase chain reaction |
3 |
|
receptors, antigen, t-cell - metabolism |
3 |
|
receptors, tumor necrosis factor - administration & dosage - genetics - metabolism |
3 |
|
recombinant fusion proteins - metabolism |
3 |
|
red-cell aplasia, pure - physiopathology - therapy |
3 |
|
residence characteristics - statistics & numerical data |
3 |
|
rna, viral - blood - genetics |
3 |
|
safety |
3 |
|
sarcoma - pathology |
3 |
|
sarcoma, follicular dendritic cell |
3 |
|
sea deletion |
3 |
|
sh3 domain |
3 |
|
small intestine |
3 |
|
social conditions - statistics & numerical data |
3 |
|
splenomegaly - complications |
3 |
|
splenomegaly - etiology |
3 |
|
spontaneous self-concept |
3 |
|
steroid isomerases |
3 |
|
steroids |
3 |
|
subcellular fractions - metabolism |
3 |
|
submandibular gland - pathology |
3 |
|
succinate dehydrogenase |
3 |
|
succinate dehydrogenase - antagonists & inhibitors - pharmacology |
3 |
|
t cells |
3 |
|
t(8 |
3 |
|
t(9 |
3 |
|
t-lymphocytes - immunology - pathology |
3 |
|
taiwan |
3 |
|
targeted therapy |
3 |
|
tel/aml1 fusion |
3 |
|
telomere |
3 |
|
teniposide - administration & dosage |
3 |
|
thalassaemia |
3 |
|
thalassemia intermedia |
3 |
|
thrombocytosis |
3 |
|
thrombocytosis - blood - genetics - physiopathology |
3 |
|
thrombocytosis - diagnosis |
3 |
|
thrombosis - complications |
3 |
|
thymectomy |
3 |
|
time factors |
3 |
|
transcription |
3 |
|
transcription factors |
3 |
|
transcription factors - genetics |
3 |
|
transcription, genetic |
3 |
|
treatment |
3 |
|
true exfoliation |
3 |
|
tumor virus infections - genetics - immunology - microbiology |
3 |
|
twenty statements test |
3 |
|
unnecessary procedures |
3 |
|
vascular endothelial growth factor a - metabolism |
3 |
|
vegf |
3 |
|
vidarabine - administration & dosage - adverse effects - analogs & derivatives |
3 |
|
vincristine - administration & dosage |
3 |
|
vitamin b 12 deficiency - complications |
3 |
|
vitamin b12 deficiency |
3 |
|
young adult |
3 |
|
zebrafish - embryology - genetics - metabolism |
3 |
|
Ī±-thalassemia |
3 |
|
Ī²-thalassemia |
3 |
|
+8 |
2 |
|
3p21 |
2 |
|
9q34 deletion |
2 |
|
abi-1 |
2 |
|
acute megakaryoblastic leukaemia |
2 |
|
adaptor proteins, signal transducing |
2 |
|
adjuvant therapy |
2 |
|
african americans - genetics |
2 |
|
alpha-thalassemia - blood - diagnosis - genetics |
2 |
|
alpha-thalassemia - ethnology - genetics |
2 |
|
alpha-thalassemia-epidemiology |
2 |
|
aml |
2 |
|
analysis of variance |
2 |
|
anemia - genetics - physiopathology |
2 |
|
anemia, aplastic - genetics |
2 |
|
anemia, sickle cell - genetics - metabolism |
2 |
|
anoxia - diagnosis - etiology |
2 |
|
anti-lepore |
2 |
|
antigens, cd34 - metabolism |
2 |
|
antigens, cd38 - metabolism |
2 |
|
antigens, neoplasm - analysis |
2 |
|
antineoplastic combined chemotherapy protocols - pharmacology |
2 |
|
antithrombin iii - analysis |
2 |
|
antithrombin iii - metabolism |
2 |
|
antithrombin iii deficiency |
2 |
|
apoptosis |
2 |
|
ascites - genetics - pathology |
2 |
|
asian |
2 |
|
australia |
2 |
|
basophils - pathology |
2 |
|
beta-globins - genetics |
2 |
|
beta-thalassemia - blood - genetics |
2 |
|
beta-thalassemia - diagnosis - genetics |
2 |
|
beta-thalassemia - ethnology - genetics |
2 |
|
beta-thalassemia - genetics - metabolism |
2 |
|
beta-thalassemia-epidemiology |
2 |
|
binding sites |
2 |
|
binding, competitive |
2 |
|
blast crisis |
2 |
|
blood cells - metabolism |
2 |
|
blood coagulation |
2 |
|
blood group antigens - genetics - immunology |
2 |
|
blood grouping and crossmatching |
2 |
|
blood, coagulation |
2 |
|
blood, haemodilution |
2 |
|
body mass index |
2 |
|
bone marrow - chemistry - physiology |
2 |
|
bone marrow - pathology |
2 |
|
bone marrow cells - pathology |
2 |
|
burkitt lymphoma - genetics - mortality - therapy |
2 |
|
cacna2d3 |
2 |
|
carcinoma, small cell - genetics - pathology |
2 |
|
carrier proteins - genetics |
2 |
|
cell differentiation - genetics - immunology |
2 |
|
cell movement - immunology |
2 |
|
cell nucleolus - ultrastructure |
2 |
|
cell nucleus - ultrastructure |
2 |
|
cell proliferation |
2 |
|
cell transformation, neoplastic - genetics - immunology |
2 |
|
chemotaxis, leukocyte |
2 |
|
china - epidemiology |
2 |
|
china - epidemiology - ethnology |
2 |
|
chromosome disorders |
2 |
|
chromosome mapping |
2 |
|
chromosomes, human, pair 10 |
2 |
|
chromosomes, human, pair 13 - genetics |
2 |
|
chromosomes, human, pair 17 - genetics |
2 |
|
chromosomes, human, pair 2 |
2 |
|
chromosomes, human, pair 2 - genetics |
2 |
|
chromosomes, human, pair 22 |
2 |
|
chromosomes, human, pair 22 - genetics |
2 |
|
chromosomes, human, pair 7 |
2 |
|
chromosomes, human, pair 7 - genetics |
2 |
|
chronic disease |
2 |
|
chronic eosinophilic leukemia |
2 |
|
chronic myelogenous leukaemia |
2 |
|
chronic myelogenous leukemia |
2 |
|
chronic myeloid leukaemia |
2 |
|
clinical decision making |
2 |
|
clinical effectiveness |
2 |
|
clinical outcome |
2 |
|
clonal evolution |
2 |
|
cmml |
2 |
|
codon |
2 |
|
colony-forming units assay |
2 |
|
color |
2 |
|
cord blood |
2 |
|
culinary medicine |
2 |
|
curriculum |
2 |
|
cytogenetic analysis - methods |
2 |
|
cytokine |
2 |
|
cytokines - biosynthesis |
2 |
|
cytoplasm - ultrastructure |
2 |
|
cytoskeletal proteins |
2 |
|
d-fish |
2 |
|
delta-chain |
2 |
|
delta-globins - genetics |
2 |
|
dendritic cells - metabolism |
2 |
|
development |
2 |
|
diabetes mellitus |
2 |
|
diabetes mellitus, type 1 - epidemiology - genetics |
2 |
|
diabetes mellitus, type 2 - blood - complications - genetics |
2 |
|
diabetes mellitus, type 2 - blood - epidemiology - genetics |
2 |
|
differentiation |
2 |
|
digestive system neoplasms - surgery |
2 |
|
disease susceptibility - epidemiology |
2 |
|
dna - genetics |
2 |
|
dna damage |
2 |
|
dna nucleotidylexotransferase |
2 |
|
dna primers |
2 |
|
dna primers - genetics |
2 |
|
dna probes - chemistry |
2 |
|
dna-cytosine methylases |
2 |
|
dosage compensation, genetic |
2 |
|
dot blot hybridization |
2 |
|
down syndrome |
2 |
|
down syndrome - blood - complications - genetics |
2 |
|
down syndrome - complications |
2 |
|
down syndrome screening |
2 |
|
down's syndrome |
2 |
|
dysphagia |
2 |
|
ectropion |
2 |
|
education |
2 |
|
education, medical, undergraduate |
2 |
|
een family |
2 |
|
electrophoresis |
2 |
|
emotion |
2 |
|
entropion |
2 |
|
environmental |
2 |
|
eosinophilic chloroma |
2 |
|
eosinophils |
2 |
|
eosinophils - pathology |
2 |
|
eosinophils - physiology |
2 |
|
epirubicin |
2 |
|
erythrocyte indices |
2 |
|
erythrocytes - immunology |
2 |
|
erythrocytes - ultrastructure |
2 |
|
erythropoiesis |
2 |
|
european continental ancestry group |
2 |
|
ex vivo expansion |
2 |
|
expanded newborn screening |
2 |
|
fab classification |
2 |
|
factor vii |
2 |
|
factor vii - genetics |
2 |
|
fibrinogen |
2 |
|
fibrinogen - genetics - metabolism |
2 |
|
fluorescence in situ hybridization |
2 |
|
fluorescent antibody technique |
2 |
|
fluorescent dyes - pharmacology |
2 |
|
gene |
2 |
|
gene deletion |
2 |
|
gene expression |
2 |
|
gene expression regulation - genetics |
2 |
|
gene frequency |
2 |
|
gene fusion |
2 |
|
gene rearrangement - genetics |
2 |
|
gene rearrangement, beta-chain t-cell antigen receptor - genetics |
2 |
|
genes |
2 |
|
genes, immunoglobulin - genetics |
2 |
|
genes, p53 |
2 |
|
genetic |
2 |
|
genetic association studies |
2 |
|
genetic counselling |
2 |
|
genetic linkage |
2 |
|
genetic marker |
2 |
|
genotype-phenotype correlation |
2 |
|
globin gene mutation |
2 |
|
globins - analysis |
2 |
|
granulocyte colony-stimulating factor - administration & dosage |
2 |
|
granulocyte colony-stimulating factor - genetics |
2 |
|
haemoglobin |
2 |
|
haemolytic disease of the newborn |
2 |
|
hbe trait |
2 |
|
hbf quantitative trait locus |
2 |
|
hbh inclusion test |
2 |
|
hematologic diseases - complications |
2 |
|
hematology |
2 |
|
hematopoietic stem cell |
2 |
|
hematopoietic stem cell transplantation |
2 |
|
hematopoietic stem cells |
2 |
|
hemodilution |
2 |
|
hemoglobin a2 - genetics |
2 |
|
hemoglobin a2 - metabolism |
2 |
|
hemoglobinopathies - complications - diagnosis |
2 |
|
hemoglobinopathies - genetics - metabolism |
2 |
|
hemoglobins, abnormal - analysis - genetics |
2 |
|
hemoglobins, abnormal - genetics |
2 |
|
histone deacetylase inhibitor |
2 |
|
history of medicine |
2 |
|
homeodomain proteins - genetics - metabolism |
2 |
|
hughes flap |
2 |
|
hypereosinophilic syndrome - genetics |
2 |
|
hypereosinophilic syndrome - genetics - metabolism - radiography |
2 |
|
immunoblastic lymphadenopathy - enzymology - genetics - pathology |
2 |
|
immunohistochemistry |
2 |
|
in situ hybridization |
2 |
|
in situ hybridization, fluorescence - instrumentation - methods |
2 |
|
inclusion bodies - pathology |
2 |
|
individualism |
2 |
|
informed consent |
2 |
|
interdisciplinarity |
2 |
|
internationalisation |
2 |
|
interstitial 9q- |
2 |
|
intraoperative care |
2 |
|
introns |
2 |
|
involutional |
2 |
|
ischaemic heart disease |
2 |
|
isoantibodies - genetics - immunology |
2 |
|
isochromosomes - genetics |
2 |
|
isocitrate dehydrogenase - genetics |
2 |
|
janus kinase 2 |
2 |
|
jmml |
2 |
|
leukemia - etiology - genetics |
2 |
|
leukemia - genetics |
2 |
|
leukemia - genetics - immunology |
2 |
|
leukemia, lymphocytic, acute |
2 |
|
leukemia, lymphocytic, acute - drug therapy - mortality |
2 |
|
leukemia, lymphoid - genetics - pathology |
2 |
|
leukemia, megakaryoblastic, acute - complications |
2 |
|
leukemia, monocytic, acute - genetics - therapy |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - complications - genetics |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis - genetics - pathology |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy - genetics |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - ethnology - genetics |
2 |
|
leukemia, myeloid - drug therapy - genetics |
2 |
|
leukemia, myeloid - genetics |
2 |
|
leukemia, myeloid, acute - chemically induced - genetics |
2 |
|
leukemia, myeloid, acute - genetics - immunology - pathology |
2 |
|
leukemia, myeloid, acute - metabolism - pathology |
2 |
|
leukemia, myeloid, chronic, atypical, bcr-abl negative - genetics |
2 |
|
leukemia, myeloid, chronic-phase - genetics - pathology |
2 |
|
leukemia, myelomonocytic, acute - genetics |
2 |
|
leukemia, myelomonocytic, acute - genetics - immunology - pathology |
2 |
|
leukemia, myelomonocytic, chronic - metabolism - pathology |
2 |
|
leukemia, myelomonocytic, chronic - pathology |
2 |
|
leukemia, promyelocytic, acute - diagnosis |
2 |
|
leukemia, promyelocytic, acute - drug therapy - genetics |
2 |
|
leukemia, promyelocytic, acute - drug therapy - genetics - pathology |
2 |
|
leukemia-lymphoma, adult t-cell - genetics - immunology |
2 |
|
leukemia-lymphoma, adult t-cell - genetics - mortality - therapy |
2 |
|
leukemia-lymphoma, adult t-cell - genetics - pathology |
2 |
|
leukocytes - pathology |
2 |
|
leukocytosis - blood |
2 |
|
leukocytosis - etiology |
2 |
|
leukopoiesis |
2 |
|
lipids - blood |
2 |
|
lipoproteins - blood |
2 |
|
listed building |
2 |
|
logistic models |
2 |
|
lower lid defect |
2 |
|
lung neoplasms - secondary |
2 |
|
lymphoma, t-cell - enzymology - genetics - pathology |
2 |
|
lymphoma, t-cell, peripheral - enzymology - genetics - pathology |
2 |
|
macromolecular substances |
2 |
|
masked Ī²-thalassemia (Ī²-thal) |
2 |
|
mass screening |
2 |
|
mass screening - methods |
2 |
|
mass screening - utilization |
2 |
|
maternal health services - statistics & numerical data |
2 |
|
mch |
2 |
|
mcv |
2 |
|
mean corpuscular volume |
2 |
|
medical museum |
2 |
|
megakaryocytes - metabolism - pathology |
2 |
|
megakaryocytic ploidy |
2 |
|
membrane glycoproteins - metabolism |
2 |
|
metaphase |
2 |
|
metastasis |
2 |
|
methotrexate |
2 |
|
microscopy, electron |
2 |
|
mll |
2 |
|
monosomy |
2 |
|
monosomy - genetics |
2 |
|
monosomy 7 |
2 |
|
morphology |
2 |
|
multigene family - genetics |
2 |
|
multiple myeloma - genetics |
2 |
|
mutation, missense - genetics |
2 |
|
mycosis fungoides - drug therapy - radiotherapy |
2 |
|
myeloblastic transformation |
2 |
|
myelodysplastic syndromes |
2 |
|
myelodysplastic syndromes - complications - diagnosis - genetics |
2 |
|
myelodysplastic syndromes - diagnosis - genetics |
2 |
|
myelodysplastic syndromes - genetics - pathology |
2 |
|
myeloid leukemia |
2 |
|
myeloid-lymphoid leukemia protein - genetics - metabolism |
2 |
|
myeloproliferative disorders - complications - diagnosis - genetics |
2 |
|
myeloproliferative disorders - diagnosis |
2 |
|
myeloproliferative disorders - genetics - pathology |
2 |
|
myocardial ischemia - blood - complications - genetics |
2 |
|
n-ras mutation |
2 |
|
nbs1 |
2 |
|
neoplasm recurrence, local - epidemiology |
2 |
|
neoplastic stem cells - chemistry |
2 |
|
neuroblastoma |
2 |
|
neuroblastoma - genetics - pathology |
2 |
|
neurofibromatosis 1 - complications - genetics |
2 |
|
neutrophils - physiology |
2 |
|
npc |
2 |
|
organ specificity |
2 |
|
ovarian neoplasms - genetics - pathology |
2 |
|
ovary |
2 |
|
oximetry |
2 |
|
oxygen - blood |
2 |
|
oxygen - metabolism |
2 |
|
paediatric mds |
2 |
|
peptide hydrolases - analysis |
2 |
|
peritoneal diseases - metabolism - pathology |
2 |
|
piperazines - therapeutic use |
2 |
|
ploidies |
2 |
|
pml-rarĪ± |
2 |
|
polycythemia |
2 |
|
polymerase chain reaction |
2 |
|
polymerase chain reaction - methods |
2 |
|
polymorphism |
2 |
|
polymorphism, genetic - genetics |
2 |
|
polymorphism, restriction fragment length |
2 |
|
polymorphism, single nucleotide |
2 |
